[DRUGS ACTIVATING FIBRINOLYSIS. THERAPEUTIC USES].
D000925:Anticoagulants; D004247:DNA; D003850:Deoxyribonuclease I; D005342:Fibrinolysis; D010600:Pharmacology; D011134:Polysaccharides; D011315:Preventive Medicine; D013299:Streptodornase and Streptokinase; D013300:Streptokinase; D013923:Thromboembolism; D013924:Thrombophlebitis; D013927:Thrombosis; D014357:Trypsin
D000925:Anticoagulants; D011134:Polysaccharides; D004247:DNA; D013299:Streptodornase and Streptokinase; D003850:Deoxyribonuclease I; D013300:Streptokinase; D014357:Trypsin
ANTICOAGULANTS; DEOXYRIBONUCLEASE; FIBRINOLYSIS; PHARMACOLOGY; POLYSACCHARIDES; PREVENTIVE MEDICINE; STREPTODORNASE AND STREPTOKINASE; THROMBOEMBOLISM; THROMBOPHLEBITIS; THROMBOSIS; TRYPSIN
FARMACI ATTIVATORI DELLA FIBRINOLISI. APPLICAZIONI TERAPEUTICHE.